Reversible aggregation of mouse prion protein derivatives with PrPSC-like structural properties

被引:0
|
作者
Lu, BY
Atanasov, I
Zhou, ZH
Chang, JY
机构
[1] Univ Texas, Inst Mol Med, Res Ctr Prot Chem, Houston, TX 77030 USA
[2] Univ Texas, Dept Biochem & Mol Biol, Houston, TX 77030 USA
[3] Univ Texas, Dept Pathol & Lab Med, Houston, TX 77030 USA
来源
JOURNAL OF PROTEIN CHEMISTRY | 2003年 / 22卷 / 02期
关键词
mouse prion protein; prion protein derivatives; carbamylation of reduced prion protein; refolding of prion protein; aggregation of prion protein derivatives; electron microscopy; reversible aggregation of prion protein derivatives;
D O I
10.1023/A:1023466728762
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Three carbamylated derivatives of reduced mouse prion protein (mPrP) were isolated during the aborted oxidative folding in the presence of urea. These three prion protein derivatives (mPrP-a, mPrP-b, and mPrP-c) exist as monomer in the acidic solution (pH < 2.0) and exhibit prevalent random coil structure. However, they undergo rapid aggregation and transformation to a predominant beta-sheet structure upon exposure to ionic buffer with pH greater than 3.0. The stability of aggregates of mPrP conformers is in part dependent upon the time that they were allowed to develop. The nascent aggregates comprise a significant fraction of loosely packed mPrP monomers that can be dissociated by treatment with strong acidic solution. Matured aggregates acquired through prolonged sample incubation contain more tightly packed mPrP monomers that cannot be dissociated by strong acid but can be disaggregated by denaturant. The properties of reversible aggregation of mPrP-a, mPrP-b, and mPrP-c bear a striking resemblance to that observed with aggregates of hamster PrPSC.
引用
收藏
页码:115 / 126
页数:12
相关论文
共 50 条
  • [31] Structural and Dynamic Properties of the Human Prion Protein
    Chen, Wei
    van der Kamp, Marc W.
    Daggettt, Valerie
    BIOPHYSICAL JOURNAL, 2014, 106 (05) : 1152 - 1163
  • [32] Structural properties of recombinant human prion protein
    Jackson, G
    Hill, A
    Joseph, C
    Clarke, A
    Collinge, J
    PRIONS AND BRAIN DISEASES IN ANIMALS AND HUMANS, 1998, 295 : 197 - 202
  • [33] Aggregation Condition-Structure Relationship of Mouse Prion Protein Fibrils
    Fridmanis, Jekabs
    Toleikis, Zigmantas
    Sneideris, Tomas
    Ziaunys, Mantas
    Bobrovs, Raitis
    Smirnovas, Vytautas
    Jaudzems, Kristaps
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (17)
  • [34] Prion-Like Propagation of Protein Aggregation and Related Therapeutic Strategies
    Kaufman, Sarah K.
    Diamond, Marc I.
    NEUROTHERAPEUTICS, 2013, 10 (03) : 371 - 382
  • [35] Prion-Like Propagation of Protein Aggregation and Related Therapeutic Strategies
    Sarah K. Kaufman
    Marc I. Diamond
    Neurotherapeutics, 2013, 10 : 371 - 382
  • [36] Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization
    Kazlauskaite, J
    Sanghera, N
    Sylvester, I
    Vénien-Bryan, C
    Pinheiro, TJT
    BIOCHEMISTRY, 2003, 42 (11) : 3295 - 3304
  • [37] Comparison studies of the structural stability of rabbit prion protein with human and mouse prion proteins
    Zhang, Jiapu
    JOURNAL OF THEORETICAL BIOLOGY, 2011, 269 (01) : 88 - 95
  • [38] In vitro aggregation assays for the characterization of α-synuclein prion-like properties
    Narkiewicz, Joanna
    Giachin, Gabriele
    Legname, Giuseppe
    PRION, 2014, 8 (01) : 19 - 32
  • [39] Direct observation of protein folding, aggregation, and a prion-like conformational conversion
    Ding, F
    LaRocque, JJ
    Dokholyan, NV
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (48) : 40235 - 40240
  • [40] Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis
    McAlary, Luke
    Plotkin, Steven S.
    Yerbury, Justin J.
    Cashman, Neil R.
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019, 12